March 3, 2026Open Access

Promethazine-induced neuroleptic malignant syndrome under general anesthesia: a case report

Key Points

Neuroleptic malignant syndrome can occur from standard drug dosages, according to this case.
Key indicators for neuroleptic malignant syndrome diagnosis rely heavily on clinical symptoms.
Observational analysis of a single case reveals vital lessons for anesthesia practices regarding drug safety.
Highlighting the need for prompt identification can significantly improve patient outcomes in anesthesia settings.

Abstract

This case illustrates that due to individual variations, even standard drug dosages may induce neuroleptic malignant syndrome (NMS). Notably, NMS lacks specific laboratory findings, and its diagnosis must rely on clinical symptoms to avoid delays in early identification and treatment.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Peng Liu

Zhi-Min Liao

Journals

SHILAP Revista de lepidopterología

Frontiers in Psychiatry

Actions

Institutions

Sichuan University

West China Second University Hospital of Sichuan University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Promethazine-induced neuroleptic malignant syndrome under general anesthesia: a case report

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider